Print Page  Close Window

SEC Filings

S-1
VITAE PHARMACEUTICALS, INC filed this Form S-1 on 08/12/2014
Entire Document
 

Table of Contents


TABLE OF CONTENTS

 
  Page  

Prospectus Summary

    1  

Risk Factors

    11  

Information Regarding Forward-Looking Statements

    44  

Industry and Market Data

    45  

Use of Proceeds

    46  

Dividend Policy

    47  

Capitalization

    48  

Dilution

    50  

Selected Financial Data

    52  

Management's Discussion and Analysis of Financial Condition and Results of Operations

    54  

Business

    74  

Management

    119  

Executive Compensation

    126  

Certain Relationships and Related Party Transactions

    141  

Principal Stockholders

    143  

Description of Capital Stock

    146  

Shares Eligible for Future Sale

    150  

Material United States Tax Considerations to Non-U.S. Holders

    152  

Underwriting

    156  

Legal Matters

    164  

Experts

    164  

Where You Can Find Additional Information

    164  

Index to Financial Statements

    F-1  

        You should rely only on the information contained in this prospectus and any free writing prospectus we have prepared in connection with this offering. Neither we nor the underwriters have authorized anyone to provide you with information or make any representations different from or in addition to those contained in this prospectus or any free writing prospectus we have prepared in connection with this offering. We and the underwriters take no responsibility for and can provide no assurance as to the reliability of any information that others may give you. We are offering to sell shares of common stock and seeking offers to buy shares of our common stock only in jurisdictions where offers and sales are permitted. Our business, financial condition, results of operations and prospectus may have changed since that date.

        Unless the context indicates otherwise, as used in this prospectus, the terms "Vitae," "Company," "we," "us" and "our" refer to Vitae Pharmaceuticals, Inc. The Vitae design logo and the marks "Vitae," "Vitae Pharmaceuticals" and "Contour" are the property of Vitae. This prospectus contains additional trade names, trademarks and service marks of ours and of other companies. We do not intend our use or display of other companies' trade names, trademarks or service marks to imply a relationship with, or endorsement or sponsorship of us by, these other companies.

        For investors outside the United States: Neither we nor the underwriters have done anything that would permit this offering or possession or distribution of this prospectus in any jurisdiction where action for that purpose is required, other than in the United States. You are required to inform yourselves about and observe any restrictions relating to this offering and the distribution of this prospectus outside of the United States.